Jazz Pharmaceuticals Inc. on Monday reported fourth quarter net income of $24.5 million, or 56 cents a share, compared to $5.7 million, or 17 cents a share in the same quarter last year. Palo Alto-based Jazz (NASDAQ:JAZZ) reported revenue of $53.4 million, compared to $38.3 million in the year-ago quarter. Excluding items, the company would have earned $27.2 million, or 63 cents a share, compared to $10.8 million, or 33 cents a share. Full year 2010 net income was $32.8 million, or 83 cents a share, compared to a 2009 loss of...